, Tracking Stock Market Picks
Enter Symbol:
Edwards Lifesciences Corporation (EW) [hlAlert]

up 99.27 %

Edwards Lifesciences Corporation (EW) upgraded to Outperform by Wells Fargo

Posted on: Monday,  Mar 10, 2014  8:25 AM ET by Wells Fargo

Wells Fargo rated Outperform Edwards Lifesciences Corporation (NYSE: EW) on 03/10/2014, when the stock price was $73.06. Since
then, Edwards Lifesciences Corporation has gained 99.27% as of 01/25/2016's recent price of $145.59.
If you would have followed this Wells Fargo's recommendation on EW, you would have gained 99.27% of your investment in 686 days.

Edwards Lifesciences Corp. a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, peripheral vascular disease and critical care technologies. The company's global brands, which are sold in approximately hundred countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, LifeStent, PERIMOUNT Magna and Swan-Ganz. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the United States Patent and Trademark Office.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/10/2014 8:25 AM Buy
as of 10/17/2014
1 Week down  -5.34 %
1 Month down  -3.37 %
3 Months up  16.41 %
1 YTD up  35.50 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/10/2013 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy